Welcome to LookChem.com Sign In|Join Free
  • or
Benzenamine, 2,6-dichloro-3-methyl-N-phenyl-, also known as 2,6-dichloro-N-phenyl-3-methylbenzenamine, is an organic compound with the chemical formula C13H11Cl2N. It is a derivative of aniline, featuring a benzene ring with a methyl group at the 3-position, two chlorine atoms at the 2 and 6 positions, and a phenyl group attached to the nitrogen atom. Benzenamine, 2,6-dichloro-3-methyl-N-phenyl- is primarily used as an intermediate in the synthesis of various pharmaceuticals, agrochemicals, and dyes. Due to its chemical structure, it exhibits reactivity and can participate in various chemical reactions, such as nucleophilic substitution and electrophilic aromatic substitution. It is important to handle Benzenamine, 2,6-dichloro-3-methyl-N-phenyl- with care, as it may have potential health and environmental hazards.

1618-57-1

Post Buying Request

1618-57-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1618-57-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1618-57-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,6,1 and 8 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1618-57:
(6*1)+(5*6)+(4*1)+(3*8)+(2*5)+(1*7)=81
81 % 10 = 1
So 1618-57-1 is a valid CAS Registry Number.

1618-57-1Relevant academic research and scientific papers

FENAMATE 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS ANTIINFLAMMATORY AGENTS

-

, (2008/06/13)

The present invention is novel compounds which are 1,3,4-thiadiazoles and 1,3,4-oxadiazoles, and pharamaceutically acceptable acid addition or base salts thereof having activity as inhibitors of singly or together 5-lipoxygenase and cyclooxygenase, and pharmaceutical compositions or methods of use therefor.

FENAMIC ACID HYDROXAMATE DERIVATIVES HAVING CYCLOOXYGENASE AND 5-LIPOXYGENASE INHIBITION

-

, (2008/06/13)

The present invention is novel selected hydroxamic acid derivatives of fenamic acids having 5-lipoxygenase and cyclooxygenase inhibiting properties, pharmaceutical compositions for treating conditions advantageously affected by the inhibition and methods

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1618-57-1